Miradas

Treball Final del Grau en Comunicació Audiovisual. Codi: CA0932. Curs: 2015/2016Miradas es un cortometraje de ficción del subgénero de terror de metraje encontrado producido por FalcóFilms, un equipo formado por cuatro estudiantes del grado en Comunicación Audiovisual de la Universitat Jaume I de Castellón. Para la creación de la obra se ha indagado en el género de terror y sus recursos expresivos y narrativos más empleados a lo largo su historia. Se han considerado las nociones clave de la teoría del guion para una elaboración correcta del mismo, analizando la colocación de los plot points y de las catálisis en los momentos oportunos. Además de controlar los conceptos de focalización y ocularización a lo largo de la obra cinematográfica para crear mayor interés en el espectador. Hemos atravesado un largo recorrido de investigación teórica y de visionado de otras obras, lo que nos ha ayudado a conseguir nuestros principales objetivos: contar el relato a través del subgénero de metraje encontrado, controlando el tiempo de la narración y el fuera de campo. Así como la capacidad de trabajar la desorientación para crear suspense, sugerir y no mostrar para despertar la emoción de terror en el espectador y crear una atmósfera propia donde se desarrolle la narración.Looks is a short fiction horror subgenre of found footage by FalcóFilms, produced by a team of four students of the degree in Audiovisual Communication at the Universitat Jaume I of Castellón. For the creation of the work we have delved into the horror genre and narrative expressive and more prevalent throughout the story’s resources. We have considered the key notions of the theory of the screenplay for proper preparation, analyzing the placement of the plot points and catalysis at appropriate times. In addition to controlling the concepts of tocus and ocularisation along the cinematographic work to create greater interest in the viewer. We have gone through a long journey of theoretical research and viewing other films, which has helped us achieve our main goals: to tell the story through the subgenre of found footage, controlling the time of narration and offscreen. As well as the ability to deal with the disorientation. All these aspects contributed to create suspense and make you think about the characters' personality. Nonetheless, the fact that viewers do not see the danger brings out feelings of horror, thus creating an atmosphere where the narration develops itself

The usefulness of 3D printed heart models for medical student education in congenital heart disease

Abstract Background Three-dimensional (3D) printing technology enables the translation of 2-dimensional (2D) medical imaging into a physical replica of a patient’s individual anatomy and may enhance the understanding of congenital heart defects (CHD). We aimed to evaluate the usefulness of a spectrum of 3D-printed models in teaching CHD to medical students. Results We performed a prospective, randomized educational procedure to teach fifth year medical students four CHDs (atrial septal defect (ASD, n = 74), ventricular septal defect (VSD, n = 50), coarctation of aorta (CoA, n = 118) and tetralogy of Fallot (ToF, n = 105)). Students were randomized into printing groups or control groups. All students received the same 20 min lecture with projected digital 2D images. The printing groups also manipulated 3D printed models during the lecture. Both groups answered an objective survey (Multiple-choice questionnaire) twice, pre- and post-test, and completed a post-lecture subjective survey. Three hundred forty-seven students were included and both teaching groups for each CHD were comparable in age, sex and pre-test score. Overall, objective knowledge improved after the lecture and was higher in the printing group compared to the control group (16.3 ± 2.6 vs 14.8 ± 2.8 out of 20, p < 0.0001). Similar results were observed for each CHD (p = 0.0001 ASD group; p = 0.002 VSD group; p = 0.0005 CoA group; p = 0.003 ToF group). Students’ opinion of their understanding of CHDs was higher in the printing group compared to the control group (respectively 4.2 ± 0.5 vs 3.8 ± 0.4 out of 5, p < 0.0001). Conclusion The use of 3D printed models in CHD lectures improve both objective knowledge and learner satisfaction for medical students. The practice should be mainstreamed

Impact of Sophrology on cardiopulmonary fitness in teenagers and young adults with a congenital heart disease: The SOPHROCARE study rationale, design and methods

International audienceBackground: Recent advances in the field of congenital heart disease (CHD) have significantly improved the overall prognosis. Now more attention is being given to health-related quality of life (HRQoL) and promotion of physical activity. Non-invasive relaxation therapy may be effective in cardiac patients concerned with exercise-induced dyspnoea. The SOPHROCARE randomised trial aims to assess the impact of Caycedian Sophrology on cardiopulmonary fitness in adolescents and young adults with CHD.Methods: The SOPHROCARE trial is a nationwide, multicentre, randomised, controlled study in CHD patients aged from 13 to 25 years old. Patients will be randomised into 2 groups (8 Sophrology group sessions vs. no intervention). The primary outcome is the change in percent predicted maximum oxygen uptake (VO2max) between baseline and 12-month follow-up. A total of 94 patients in each group is required to observe a significant increase of 10% in VO2max with a power of 80% and an alpha risk of 5%. The secondary outcomes are: clinical outcomes, cardiopulmonary exercise test parameters (VE/VCO2 slope, ventilatory anaerobic threshold, oxygen pulse, respiratory response to hypercapnia), health-related quality of life score (PedsQL), physical and psychological status.Conclusion: After focusing on the survival in CHD, current research is opening on secondary prevention and patient-related outcomes. We sought to assess in the SOPHROCARE trial, if a Sophrology program, could improve exercise capacity and quality of life in youth with CHD.Trial registration: Clinicaltrials.gov (NCT03999320)

Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods

International audienceAbstract Background Advances in paediatric cardiology have improved the prognosis of children with inherited cardiac disorders. However, health-related quality of life (QoL) and physical activity have been scarcely analysed in children with inherited cardiac arrhythmia or inherited cardiomyopathy. Moreover, current guidelines on the eligibility of young athletes with inherited cardiac disorders for sports participation mainly rely on expert opinions and remain controversial. Methods The QUALIMYORYTHM trial is a multicentre observational controlled study. The main objective is to compare the QoL of children aged 6 to 17 years old with inherited cardiac arrhythmia (long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, or arrhythmogenic right ventricular dysplasia), or inherited cardiomyopathy (hypertrophic, dilated, or restrictive cardiomyopathy), to that of age and gender-matched healthy subjects. The secondary objective is to assess their QoL according to the disease’s clinical and genetic characteristics, the level of physical activity and motivation for sports, the exercise capacity, and the socio-demographic data. Participants will wear a fitness tracker (ActiGraph GT3X accelerometer) for 2 weeks. A total of 214 children are required to observe a significant difference of 7 ± 15 points in the PedsQL, with a power of 90% and an alpha risk of 5%. Discussion After focusing on the survival in children with inherited cardiac disorders, current research is expanding to patient-reported outcomes and secondary prevention. The QUALIMYORYTHM trial intends to improve the level of evidence for future guidelines on sports eligibility in this population. Trial registration ClinicalTrials.gov Identifier: NCT04712136, registered on January 15th, 2021 ( https://clinicaltrials.gov/ct2/show/NCT04712136 )